These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Commentary: Biological therapy in refractory cases of uveitis and scleritis: An analysis of 18 cases from a tertiary eye care center from South India. Tyagi M Indian J Ophthalmol; 2020 Sep; 68(9):1933-1934. PubMed ID: 32823418 [No Abstract] [Full Text] [Related]
7. Assessment of the Accuracy of Using ICD-9 Codes to Identify Uveitis, Herpes Zoster Ophthalmicus, Scleritis, and Episcleritis. Pimentel MA; Browne EN; Janardhana PM; Borkar DS; Tham VM; Uchida A; Vinoya AC; Acharya NR JAMA Ophthalmol; 2016 Sep; 134(9):1001-6. PubMed ID: 27387135 [TBL] [Abstract][Full Text] [Related]
8. [New possibilities in therapy of ocular inflammation in rheumatic diseases]. Razumova IY; Godzenko AA Vestn Oftalmol; 2022; 138(6):108-114. PubMed ID: 36573954 [TBL] [Abstract][Full Text] [Related]
9. [Association of the different forms of uveitis with inflammatory rheumatic diseases and their treatment]. Stübiger N; Farrokhi S; Gkanatsas Y; Deuter C; Kötter I Z Rheumatol; 2022 Oct; 81(8):667-681. PubMed ID: 36040536 [TBL] [Abstract][Full Text] [Related]
10. Ocular manifestations of inflammatory bowel disease. Mintz R; Feller ER; Bahr RL; Shah SA Inflamm Bowel Dis; 2004 Mar; 10(2):135-9. PubMed ID: 15168814 [TBL] [Abstract][Full Text] [Related]
11. Uveitis. Dunn JP Prim Care; 2015 Sep; 42(3):305-23. PubMed ID: 26319340 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) as a research tool for identification of patients with uveitis and scleritis. Uchiyama E; Faez S; Nasir H; Unizony SH; Plenge R; Papaliodis GN; Sobrin L Ophthalmic Epidemiol; 2015 Apr; 22(2):139-41. PubMed ID: 25777314 [TBL] [Abstract][Full Text] [Related]
13. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. Fraunfelder FW; Winthrop K; Suhler E; Choi D; Fraunfelder FT Retina; 2009 Feb; 29(2):285-6; author reply 286-7. PubMed ID: 19202428 [No Abstract] [Full Text] [Related]
14. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. French DD; Margo CE Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608 [TBL] [Abstract][Full Text] [Related]
15. Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey. Erkanli L; Akova YA; Guney-Tefekli E; Tugal-Tutkun I Cornea; 2010 Jan; 29(1):26-33. PubMed ID: 19907295 [TBL] [Abstract][Full Text] [Related]
16. Ocular Inflammation in the Setting of Concomitant Systemic Autoimmune Conditions in an Older Male Population. Levitt AE; McManus KT; McClellan AL; Davis JL; Goldhardt R; Galor A Cornea; 2015 Jul; 34(7):762-7. PubMed ID: 26053887 [TBL] [Abstract][Full Text] [Related]
17. Outcome of tocilizumab treatment in refractory ocular inflammatory diseases. Silpa-Archa S; Oray M; Preble JM; Foster CS Acta Ophthalmol; 2016 Sep; 94(6):e400-6. PubMed ID: 27010181 [TBL] [Abstract][Full Text] [Related]
18. Patterns of Uveitis and Scleritis in Nepal: A Tertiary Referral Center Study. Manandhar A Ocul Immunol Inflamm; 2017; 25(sup1):S54-S62. PubMed ID: 27191731 [TBL] [Abstract][Full Text] [Related]
19. Ocular Complications in Survivors of the Ebola Outbreak in Guinea. Hereth-Hebert E; Bah MO; Etard JF; Sow MS; Resnikoff S; Fardeau C; Toure A; Ouendeno AN; Sagno IC; March L; Izard S; Lama PL; Barry M; Delaporte E; Am J Ophthalmol; 2017 Mar; 175():114-121. PubMed ID: 27998698 [TBL] [Abstract][Full Text] [Related]
20. Increased risks of autoimmune rheumatic diseases in patients with psoriasis: A nationwide population-based study. Ju HJ; Kim KJ; Kim DS; Lee JH; Kim GM; Park CJ; Bae JM J Am Acad Dermatol; 2018 Oct; 79(4):778-781. PubMed ID: 29920316 [No Abstract] [Full Text] [Related] [Next] [New Search]